Business Concept

Viscogel AB will manufacture, develop and commercialize in collaboration with partners its unique chitosan for applications in vaccine delivery and in other areas of high interest. The near-term focus is on showing clinical Proof-of-Concept in the vaccine delivery program and progressing exploratory development in other areas. The objective is to make ViscoGel^® a leading adjuvant  resulting in improved vaccines as well as fully explore and develop other potential applications.